Literature DB >> 20819662

Characteristics of abnormal menstrual cycle and polycystic ovary syndrome in community and hospital populations.

Yan-min Ma1, Rong Li, Jie Qiao, Xiao-wei Zhang, Shu-yu Wang, Qiu-fang Zhang, Li Li, Bin-bin Tu, Xue Zhang.   

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS) is considered to be the most common endocrine disorder in women of reproductive age. The involvement of an abnormal menstrual cycle in the etiology of PCOS remains unclear. We aimed to analyze the characteristics of abnormal menstrual cycles and their association with PCOS in community and hospital patient populations.
METHODS: Women with PCOS identified from 2111 permanent female residents in the community of Beijing and 506 outpatients obtained from the reproductive clinic of Peking University Third Hospital were recruited for this study, comprising the PCOS community group and the PCOS hospital group, respectively. Each group was further divided into four subgroups according to the length of menstrual cycles: <21 days; 21-34 days; 35-60 days; and >60 days. Women in each group were interviewed using a questionnaire to assess factors including age, age of menarche, menstrual cycle history, related family history, and modified Ferriman-Gallwey (mF-G) score. All women received transvaginal ultrasound scan and had fasting blood samples taken for endocrine evaluation. A two-tailed P value of <0.05 was considered significant.
RESULTS: In the community population, the prevalence of abnormal menstrual cycle was 27.19% (574/2111). The prevalence of PCOS in the community was 6.11% (129/2111) according to Rotterdam criteria. In the community group, the most common menstrual cycle length was 35-60 days, whereas for the hospital group, it was >60 days. In both the community and hospital groups, the most common phenotype of PCOS was that of Oligo/amenorrhea+PCO+ hyperandrogenism (HA) (O+P+H) (P=0.000). With increasing cycle length of 35-60 days to >60 days, the percentages of Oligo/amenorrhea+PCO (O+P) and O+P+H were found to significantly decrease in the community group and significantly increase in the hospital group (P=0.000 for each). In the hospital group, as the menstrual cycle length increased from 35-60 days to >60 days, the rate of spontaneous abortion increased significantly (P=0.000), meanwhile the rate of poorly-secreted endometrium and abnormal endometrial hyperplasia increased significantly (P=0.000).
CONCLUSIONS: The prevalence of PCOS in the Beijing community of women was 6.11%. Oligo/amenorrhea was the most common type of abnormal menstrual cycle and may be an indicator for PCOS and endometrial lesions. Gynecologists should seek relevant medical information from women in the community to promptly diagnose PCOS and then follow up patients for potential development of subsequent complications.

Entities:  

Mesh:

Year:  2010        PMID: 20819662

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  13 in total

1.  Expression and clinical significance of the HIF-1a/ET-2 signaling pathway during the development and treatment of polycystic ovary syndrome.

Authors:  Fan Wang; Zhenghong Zhang; Zhaokai Wang; Kaizhuan Xiao; Qing Wang; Jingqian Su; Zhengchao Wang
Journal:  J Mol Histol       Date:  2015-01-23       Impact factor: 2.611

2.  Polycystic ovary syndrome is linked with the fat mass obesity (FTO) gene variants rs17817449 and rs1421085 in western Saudi Arabia.

Authors:  Sherin Bakhashab; Asma A Batarfi; Najlaa Filimban; Osama S Bajouh; Ashraf Dallol; Mohammed H Alqahtani
Journal:  Bioinformation       Date:  2021-11-30

3.  Prevalence of Polycystic Ovary Syndrome Phenotypes Using Updated Criteria for Polycystic Ovarian Morphology: An Assessment of Over 100 Consecutive Women Self-reporting Features of Polycystic Ovary Syndrome.

Authors:  Nina M Clark; Amanda J Podolski; Eric D Brooks; Donna R Chizen; Roger A Pierson; Denis C Lehotay; Marla E Lujan
Journal:  Reprod Sci       Date:  2014-02-11       Impact factor: 3.060

Review 4.  Body image concerns in individuals diagnosed with benign gynaecological conditions: scoping review and meta-synthesis.

Authors:  Katherine Sayer-Jones; Kerry A Sherman
Journal:  Health Psychol Behav Med       Date:  2021-05-15

5.  Study on the proportion and determinants of polycystic ovarian syndrome among health sciences students in South India.

Authors:  Nitin Joseph; Aditya G R Reddy; Divya Joy; Vishakha Patel; Pooja Santhosh; Shatarupa Das; Siddharth K Reddy
Journal:  J Nat Sci Biol Med       Date:  2016 Jul-Dec

6.  Clinical and Biochemical Characteristics in PCOS Women With Menstrual Abnormalities.

Authors:  Vasiliki Christodoulopoulou; Eftihios Trakakis; Vasilios Pergialiotis; Melpomeni Peppa; Charalampos Chrelias; Dimitrios Kassanos; Nikolaos Papantoniou
Journal:  J Family Reprod Health       Date:  2016-12

7.  Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Chris Kite; Ian M Lahart; Islam Afzal; David R Broom; Harpal Randeva; Ioannis Kyrou; James E Brown
Journal:  Syst Rev       Date:  2019-02-12

8.  Prevalence of polycystic ovary syndrome in young women from North India: A Community-based study.

Authors:  Harmandeep Gill; Pallavi Tiwari; Preeti Dabadghao
Journal:  Indian J Endocrinol Metab       Date:  2012-12

9.  Risk factors for medication-induced amenorrhea in first-episode female Chinese patients with schizophrenia treated with risperidone.

Authors:  Haizhi Chen; Mincai Qian; Xinhua Shen; Shengliang Yang; Jianhong Yang; Juanfang Song; Xiaocong Fei; Baiping Tao; Baohua Song; Lihua Ren; Zhongxia Shen
Journal:  Shanghai Arch Psychiatry       Date:  2013-02

10.  Relationships between Serum Luteinizing Hormone Level, Endometrial Thickness and Body Mass Index in Polycystic Ovary Syndrome Patients with and without Endometrial Hyperplasia.

Authors:  Fariba Ramezanali; Gholamreza Khalili; Arezoo Arabipoor; Narges Bagheri Lankarani; Ashraf Moini
Journal:  Int J Fertil Steril       Date:  2016-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.